Henry Schein Inc. (HSIC) Stock

Henry Schein Inc. trades at a P/E ratio of 21.24, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 12.71 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.49 indicates reasonable value when growth is considered.

With a beta of 0.86, Henry Schein Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.33 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Henry Schein Inc. achieves a profit margin of 3.05%, meaning it retains $3.05 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 5.40% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 8.12% and ROA at 4.30%, the company achieves moderate returns on invested capital.

Henry Schein Inc.'s revenue grew by 3.30% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 12.50% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against MEDICAL DISTRIBUTION industry averages for proper context.

Henry Schein Inc. has a market capitalization of $8.0B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 121.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DISTRIBUTION industry, it competes with other firms in this sector.

Henry Schein Inc.'s book value per share is $28.26, while the current stock price is $62.32, resulting in a price-to-book (P/B) ratio of 2.21. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

15 analysts cover HSIC with 33% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $73.23 implies 17.5% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:3 Strong Buy, 2 Buy, 9 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.